Shenzhen Stock Exchange Code: 301087
Stock Abbreviation: KeFu Medical
Announcement Number: 2026-048
KeFu Medical Technology Co., Ltd. (hereinafter referred to as "the Company") held the fourth meeting of the third board of directors on April 14, 2026, to review and approve the proposal on the share buyback plan. The Company plans to use its own funds to repurchase its ordinary shares (A shares) through centralized bidding for the purpose of implementing an employee stock ownership plan or equity incentives. The total amount for the buyback is not less than RMB 100 million (inclusive) and not more than RMB 200 million (inclusive), with a repurchase price not exceeding RMB 86.60 per share (inclusive). The buyback period is within twelve months from the date of the board's approval of the buyback plan. For specific details, please refer to the relevant announcements disclosed by the Company on the Giant Tide Information Network (www.cninfo.com.cn).